Doing Business At the intersection of science, law, and policy

Your global business partners for addressing legal, scientific, and regulatory challenges.

Competitive Advantage

Bergeson & Campbell, P.C. (B&C®), a Washington D.C. law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product approval and regulation, product defense, and associated business issues. 

We help companies that make and use chemicals commercialize their products, maintain compliance, and gain competitive advantage as they market their products throughout the world. Our Mission is to get them to market faster and more efficiently than the competition.

More About Us
Lab and planting seeds

Knowledge & Insights

  January 3, 2024
Memoranda
Forecast for U.S. Federal and International Chemical Regulatory Policy 2024

Click here for a PDF brochure of the memorandum Bergeson & Campbell, P.C. (B&C®) and its global consulting affiliate The Acta Group (Acta®)...

  August 22, 2023
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  February 16, 2024
Memoranda
EPA Extends Submission Deadline for Polymer Exemption Reports and Accompanying Claims

The U.S. Environmental Protection Agency (EPA) published a final rule on February 16, 2024, amending the Toxic Substances Control Act (TSCA)...

  February 15, 2024
Monthly Federal Developments Memorandum
Recent Federal Developments for February 2024

...

  February 14, 2024
Memoranda
EPA Releases Final TSCA Fees Rule

On February 8, 2024, the Environmental Protection Agency (EPA) announced its final amendments to the 2018 final rule that established fees for the...

  January 30, 2024
Memoranda
EPA Holds Webinar on PFAS Reporting Rule Requirements

On January 25, 2024, the U.S. Environmental Protection Agency (EPA) held a webinar on EPA’s Toxic Substances Control Act (TSCA) Section 8(a)(7) rule...

  January 29, 2024
Memoranda
Senate Committee Holds Hearing on TSCA Implementation

The Senate Environment and Public Works Committee held a hearing on January 24, 2024, on “Oversight of Toxic Substances Control Act (TSCA)...

  January 16, 2024
Monthly Federal Developments Memorandum
Recent Federal Developments for January 2024

TSCA/FIFRA/TRI EPA Publishes Final SNURs On Certain Chemical Substances: The U.S. Environmental Protection Agency (EPA) published final significant...

Seminars & Webinars

  December 11, 2023
Seminars & Webinars
TSCA Developments 2024, March 5, 2024, via webinar

Chemical Watch presents TSCA Developments 2024, providing an in-depth focus on recent regulatory updates and proposed next steps to stimulate...

  February 21, 2024
Seminars & Webinars
Preparing for 2024 TSCA Chemical Data Reporting, March 6, 2024, 12:00 pm – 1:00 pm (EST), via webinar

The Alliance for Chemical Distribution (ACD) presents “Preparing for 2024 TSCA Chemical Data Reporting.” During this webinar Bergeson...

  December 18, 2023
Seminars & Webinars
FIFRA Hot Topics, March 12, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

Register now to join Bergeson & Campbell, P.C. (B&C®) for “FIFRA Hot Topics,” a complimentary webinar covering key priorities for the...

We partner with our clients to help them get products quickly and efficiently to market–in any country or locale–and keep them there.

Our Firms
Map of Bergeson & Campbell locations

our people

Government affairs experts, including eight high-level EPA alumni. Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, seven Ph.D.'s. Trusted, respected, and highly rated attorneys who have worked on some of the toughest regulatory and legal issues of our time.

B&C, Acta, and BCCM provide a full range of global support for the commercialisation of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.

Hexagons image collage

A true business partner with clients, B&C delivers vital expertise in business strategy development, compliance planning, product defense, policy advocacy, and related activities.